AHNAK and triple-negative breast carcinoma: These data seem to suggest that AHNAK is abnormally highly expressed in breast cancer and that it can promote tumor progression by inducing fibroblast migration and extracellular matrix destruction around Triple-negative breast cancer (TNBC) cells.